Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI

被引:33
|
作者
Lee, Sunyoung [1 ,2 ]
Kim, Myeong-Jin [1 ,2 ]
Kim, Sohee [3 ,4 ]
Choi, Dongil [3 ,4 ]
Jang, Kee-Taek [5 ]
Park, Young Nyun [6 ]
机构
[1] Yonsei Univ, Coll Med, Dept Radiol, Severance Hosp, 50-1 Yonsei Ro, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Severance Hosp, 50-1 Yonsei Ro, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Dept Radiol, Samsung Med Ctr, Seoul, South Korea
[4] Sungkyunkwan Univ, Sch Med, Ctr Imaging Sci, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Dept Pathol, Samsung Med Ctr, Seoul, South Korea
[6] Yonsei Univ, Dept Pathol, BK21 PLUS Project Med Sci, Coll Med, Seoul, South Korea
关键词
Bile duct; Intraductal papillary neoplasm; Prognosis; Magnetic resonance imaging; CLINICOPATHOLOGICAL FEATURES; MUCINOUS NEOPLASM; CHOLANGIOCARCINOMA; TUMORS; GUIDELINES; MANAGEMENT; SPECTRUM; IPMN;
D O I
10.1016/j.jhep.2018.12.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Imaging characteristics for discriminating the malignant potential of intraductal papillary neoplasm of the bile duct (IPNB) still remain unclear. This study aimed to define the magnetic resonance (MR) imaging findings that help to differentiate IPNB with an associated invasive carcinoma from IPNB with intraepithelial neoplasia and to investigate their significance with respect to long-term outcomes in patients with surgically resected IPNB. Methods: This retrospective study included 120 patients with surgically resected IPNB who underwent preoperative MR imaging with MR cholangiography before surgery from January 2008 and December 2017 in two tertiary referral centers. Clinical and MR imaging features of IPNB with intraepithelial neoplasia (n = 34) and IPNB with an associated invasive carcinoma (n = 86) were compared. Regarding significant features for discriminating IPNB with or without an associated invasive carcinoma, recurrence-free survival (RFS) rates were evaluated. Results: Significant MR imaging findings for differentiating IPNB with an associated invasive carcinoma from IPNB with intraepithelial neoplasia were intraductal visible mass, tumor size >= 2.5 cm, multiplicity of the tumor, bile duct wall thickening, and adjacent organ invasion (all p <= 0.002). The 1-, 3-, and 5-year RFS rates for surgically resected IPNB were 93.8%, 79.1%, and 70.0%, respectively. RFS rates were significantly lower in patients with each significant MR imaging finding of IPNB with an associated invasive carcinoma than in those without significant MR imaging findings (all p <= 0.039). Conclusions: MR imaging with MR cholangiography may be helpful in differentiating IPNB with an associated invasive carcinoma from IPNB with intraepithelial neoplasia. Significant MR imaging findings of IPNB with an associated invasive carcinoma have a negative impact on RFS. Lay summary: Significant magnetic resonance imaging findings that differentiated between an intraductal papillary neoplasm of the bile duct (IPNB) with an associated invasive carcinoma and an IPNB with intraepithelial neoplasia were intraductal visible mass, tumor size >= 2.5 cm, multiplicity of the tumor, bile duct wall thickening, and adjacent organ invasion. Significant magnetic resonance imaging findings of invasive IPNB have a negative impact on recurrence-free survival. (C) 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:692 / 699
页数:8
相关论文
共 50 条
  • [41] The Clinicopathological Features of Intraductal Papillary Mucinous Neoplasm of the Bile Duct: Compared With Intraductal Papillary Mucinous Neoplasm of the Pancreas
    Toyoki, Yoshikazu
    Ishido, Keinosuke
    Kudo, Daisuke
    Narumi, Shunji
    Hakamada, Kenichi
    GASTROENTEROLOGY, 2012, 142 (05) : S456 - S456
  • [42] Long-term survival after resection of invasive pancreatic intraductal papillary mucinous neoplasm
    Pietro Addeo
    Giulia Canali
    Chloe Paul
    Pierre de Mathelin
    Gerlinde Averous
    Philippe Bachellier
    Langenbeck's Archives of Surgery, 409 (1)
  • [43] Characterization of Intraductal Papillary Neoplasm of the Bile Duct with Respect to the Histopathologic Similarities to Pancreatic Intraductal Papillary Mucinous Neoplasm
    Nakanuma, Yasuni
    Kakuda, Yuko
    Uesaka, Katsuhiko
    GUT AND LIVER, 2019, 13 (06) : 617 - 627
  • [44] Pseudomyxoma peritonei (mucinous carcinoma peritonei) preceded by intraductal papillary neoplasm of the bile duct
    Jhuang, Jie-Yang
    Hsieh, Min-Shu
    HUMAN PATHOLOGY, 2012, 43 (07) : 1148 - 1152
  • [45] Intraductal papillary neoplasm of bile duct: all rare in one
    Chaturvedi, Aprajita
    Pol, Manjunath Maruti
    Jangra, Kirti
    Singh, Priyanka
    BMJ CASE REPORTS, 2020, 13 (11)
  • [46] Malignant intraductal oncocytic papillary neoplasm of the common bile duct
    Terada, Tadashi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2012, 5 (01): : 96 - 101
  • [47] Intraductal papillary neoplasm of the bile duct accompanied by hepatogastric fistula
    Terasaki, Fumihiro
    Sugiura, Teiichi
    Uesaka, Katsuhiko
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2020, 27 (06) : 352 - 353
  • [48] ENDOSCOPIC TREATMENT OF INTRADUCTAL PAPILLARY NEOPLASM OF THE DISTAL BILE DUCT
    Pisani, Ponz De Leon R.
    Archibugi, L.
    Mariani, A.
    Tacelli, M.
    Zaccari, P.
    Rossi, G.
    Petrone, M. C.
    Arcidiacono, P. G.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S193 - S194
  • [49] Board Review Vignette: Intraductal Papillary Neoplasm of the Bile Duct
    Kohli, Divyanshoo R.
    Shah, Tilak U.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (05): : 639 - 641
  • [50] Clinicopathological Study of Resections of Intraductal Papillary Neoplasm of the Bile Duct
    Sato, Toshihiro
    Hisaka, Toru
    Sakai, Hisamune
    Ishikawa, Hiroto
    Kawahara, Ryuichi
    Goto, Yuichi
    Nomura, Yoriko
    Yasunaga, Masafumi
    Fujita, Fumihiko
    Tanigawa, Masahiko
    Naito, Yoshiki
    Akiba, Jun
    Yano, Hirohisa
    Tanaka, Hiroyuki
    Akagi, Yoshito
    Okuda, Koji
    ANTICANCER RESEARCH, 2019, 39 (08) : 4569 - 4573